• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 管理研究 • 上一篇    

循证药学和药物经济学理论在我国基本药物 目录中的应用探讨

刘强,张诗雨,李洪超,马爱霞   

  1. 中国药科大学国际医药商学院 南京,中国药科大学国际医药商学院 南京,中国药科大学国际医药商学院 南京,中国药科大学国际医药商学院 南京
  • 收稿日期:2016-06-15 修回日期:2016-06-15 出版日期:2016-10-25 发布日期:2016-10-25

Exploration of Evidence-based and Pharmacoeconomics Theory Applied in China Essential Medicine List

  1. China Pharmaceutical University,,,
  • Received:2016-06-15 Revised:2016-06-15 Online:2016-10-25 Published:2016-10-25

摘要: 目的:为了以更合理的方式对我国基本药物目录所纳入的药物进行遴选,本研究尝试应用循证药学和药物经济学理论建立科学的定量遴选体系。方法:通过参考泰国ISafE评价法和其他国家和地区基本药物目录的遴选方法,以循证药学及药物经济学为理论基础,提出更为完善的我国基本药物目录遴选体系并对其进行说明。结果和结论:通过循证药学方法以及药物经济学方法科学合理地解决了我国目前基本药物目录遴选所存在的问题,该遴选机制也可用于以后基本药物的增补、医保目录药物遴选、增补以及确定同类药物间临床首选药等方面。由于国内文献数量以及质量问题,目前该机制的开展尚存在一定的问题,但也可以为我国基本药物遴选体系的发展起到一定的参考作用。

Abstract: Objective: In order to select medicines for inclusion in the National Essential Medicine List (NEML) in a more reasonable approach, this study discusses how to set up scientific and quantitative national essential medicine selection system, based on Evidence-based medicine and Pharmacoeconomics. Methods: On this basis of Evidence-based medicine and Pharmacoeconomics, we took Thailand ISafE grading system and other essential medicine selection process into consideration. Accordingly, we proposed a more comprehensive NEML selection system and made clarification on it. Results & Conclusion: We resolved existing problems of selection of essential medicine scientifically and reasonably. This selection mechanism can also apply to supplement of essential medicine, selection and supplement medicine for national drug reimbursement list, and settle down clinically preferred drugs. So far, this mechanism’s implementation is hindered by the problem of our literature number and quality hinder, but it still play a reference role in promoting our national essential medicine selection system.